Genetic Testing Market in LAMEA is expected to register a CAGR of 12.3% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Genetic Testing Market, published by KBV research, the LAMEA Genetic Testing Market would witness market growth of 12.3% CAGR during the forecast period (2019-2025).

The Brazil market dominated the LAMEA Cardiovascular Disease Diagnosis Market by Country in 2018, growing at a CAGR of 12.3 % during the forecast period. The Argentina market is expected to witness a CAGR of 14.5% during (2019 - 2025). Additionally, The UAE market is expected to witness a CAGR of 12.6% during (2019 - 2025).

The Molecular Testing market dominated the UAE Genetic Testing Market by Technology in 2018, growing at a CAGR of 11.6 % during the forecast period. The Biochemical Testing market is expected to witness a CAGR of 12.2% during (2019 - 2025).

The Diagnostic Testing market dominated the South Africa Genetic Testing Market by Type in 2018, growing at a CAGR of 12.5 % during the forecast period. The Prenatal and Newborn Testing market is expected to witness a CAGR of 12.6% during (2019 - 2025).

Full Report:https://www.kbvresearch.com/lamea-genetic-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).

LAMEA Genetic Testing Market Segmentation

By Type

  • Predictive and Presymptomatic Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Other Types

By Technology

  • Cytogenetic Testing
  • Biochemical Testing and
  • Molecular Testing

By Application

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis and
  • Other Applications

By Country

  • Brazil Genetic Testing Market
  • Argentina Genetic Testing Market
  • UAE Genetic Testing Market
  • Saudi Arabia Genetic Testing Market
  • South Africa Genetic Testing Market
  • Nigeria Genetic Testing Market
  • Rest of LAMEA Genetic Testing Market

Companies Profiled

  • Myriad Genetics, Inc.
  • Empire Genomics LLC
  • Bio-Rad Laboratories, Inc.
  • Novartis AG
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Danaher Corporation
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Genetic Testing Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.